Privacy Analytics Names Dan Pham Vice President of Engineering
Ottawa, ON, July 09, 2015 – Privacy Analytics (https://privacy-analytics.com) – the leading provider of software that safeguards and enables personal health data for secondary purposes – announced today that Dan Pham has joined its management team as Vice President of Engineering.
Pham is leading the software development and quality assurance teams responsible for the design and continuous quality improvement of Privacy Analytics’ suite of data de-identification products. He oversees all product development activities, documentation to support effective product implementation and coordination with sales, marketing and deployment teams. His team will also supervise the software support function, which includes telephone and email, along with FAQ’s and the product support site.
“Dan’s deep expertise in software engineering and development, particularly in the health care and Internet security industries, will be a strong asset for us as we continue to lead the way in developing the industry’s only software products based on a proven de-identification methodology consistent with HIPAA standards,” said Khaled El Emam, Founder and CEO of Privacy Analytics. “The ability to safely and responsibly de-identify patient health data so that it can be accessed and used for important research and analysis is the key to solving some of healthcare greatest challenges. Under Dan’s leadership, our software is helping to make this happen.”
Pham has 17 years of experience in software engineering projects that led to customer deployments in North America, Europe, and Australia. He has a proven track record for delivering complex multi-million dollar projects on time and on budget, and has extensive experience in designing, implementing and adapting software development processes and best practices.
“This is an incredibly exciting and important time to be joining Privacy Analytics,” said Pham. “With several new products in the pipeline for 2015, my team is working hard to ensure we bring these products to market on schedule in order to meet the industry’s increasing demand to access and share health care data for secondary use.”
- Turn Data Assets into Business Opportunity Under CCPADecember 19, 2019
- How does risk-based anonymization work?December 18, 2019
- Why should I use Expert Determination over Safe Harbor?December 18, 2019
- What do I need to know about GDPR, HIPAA and CCPA to meet our regulatory and privacy obligations?December 18, 2019
- Should we invest in building our own de-identification capability?December 17, 2019
- GDPR and The Future of Clinical Trials Data SharingMarch 18, 2019
- Advancing Principled Data Practices in Support of Emerging TechnologiesMarch 15, 2019
- “Zero Risk Does Not Exist”February 7, 2019
- Is Anonymization Possible with Current Technologies?January 9, 2019
- Comparing the benefits of pseudonymisation and anonymisation under the GDPRDecember 20, 2018